RISKS AND BENEFITS OF PROPHYLACTIC ANTIMALARIAL-DRUGS

被引：17

作者：

BRECKENRIDGE, A

机构：

来源：

BRITISH MEDICAL JOURNAL | 1989年 / 299卷 / 6707期

关键词：

D O I：

10.1136/bmj.299.6707.1057

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1057 / 1058

页数：2

共 8 条

[1]

BJORKMAN A, 1989, LANCET, V2, P865

[2] AGRANULOCYTOSIS ASSOCIATED WITH MALARIA PROPHYLAXIS WITH MALOPRIM [J].

FRIMAN, G ;

NYSTROMROSANDER, C ;

JONSELL, G ;

BJORKMAN, A ;

LEKAS, G ;

SVENDSRUP, B .

BRITISH MEDICAL JOURNAL, 1983, 286 (6373) :1244-1245

[3]

GILLES HG, 1987, J INFECTION, V18, P11

[4]

MAEGRAITH BG, 1963, LANCET, V1, P401

[5] MALARIA PROPHYLAXIS - SURVEY OF THE RESPONSE OF BRITISH TRAVELERS TO PROPHYLACTIC ADVICE [J].

PHILLIPSHOWARD, PA ;

BLAZE, M ;

HURN, M ;

BRADLEY, DJ .

BRITISH MEDICAL JOURNAL, 1986, 293 (6552) :932-934

[6]

STUIVER PC, 1989, LANCET, V2, P282

[7] INTER-SUBJECT VARIABILITY IN THE METABOLISM OF PROGUANIL TO THE ACTIVE METABOLITE CYCLOGUANIL IN MAN [J].

WARD, SA ;

WATKINS, WM ;

MBERU, E ;

SAUNDERS, JE ;

KOECH, DK ;

GILLES, HM ;

HOWELLS, RE ;

BRECKENRIDGE, AM .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (06) :781-787

[8]

1983, B WORLD HEALTH ORGAN, V61, P169

← 1 →